Margaret Ancona
EVP, Strategy & Transformation · MYRIAD GENETICS INC
Individual
- 2025
- Nov 4, 2025
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Margaret Ancona files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- S. Louise Phanstiel - $495K in MYGN purchases and sales in the last 12 months
- Samraat S. Raha - $200K in MYGN purchases and sales in the last 12 months
- Rashmi Kumar - $67K in MYGN purchases and sales in the last 12 months
- Paul Bisaro - $28K in MYGN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Margaret Ancona?
Margaret Ancona is a corporate insider, tracked as EVP, Strategy & Transformation of MYRIAD GENETICS INC (MYGN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Margaret Ancona last file a Form 4?
The most recent primary Form 4 on record is dated 4 November 2025, one of 2 filings going back to 2025.
